Parenteral ceftiofur CFA administration can be considered safe in guinea pigs and chinchillas, but its clinical efficacy for the treatment of bacterial infections is unknown because of a lack of species-specific pharmacokinetic data.
Cooper et al. (Wed,) studied this question.